Patent directory · USPTO A61K / A61P
Patents matching “The United States of America as represented by the Secretary of the Army”
225 pharma patents match "The United States of America as represented by the Secretary of the Army" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 225 pharmaceutical patents matching "The United States of America as represented by the Secretary of the Army" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12209142
SARS-CoV-2 epitope-targeted peptide immunostimulants
granted -
US 11684597
Administration of tailored feedstock to increase nitro-containing amphenicol antibiotic susceptibility
granted -
US 10538749
Mutant OPAA enzymes with increased catalytic efficiency on cyclosarin
granted -
US 10421952
Mutant organophosphorus acid anhydrolase enzymes having increased catalytic efficiency on V-agents
granted -
US 10363289
Mutant OPAA enzyme with increased catalytic efficiency on GP
granted -
US 10357554
AMA-1 epitopes, antibodies, compositions, and methods of making and using the same
granted -
US 10342791
Regimens of tafenoquine for prevention of malaria in malaria-naive subjects
granted -
US 10335465
Mutant OPAA enzyme with increased catalytic efficiency on organophosphorus compound GP
granted -
US 10307477
Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment
granted -
US 10260054
Engineered organophosphorus acid anhydrolases and methods of use thereof
granted -
US 10124043
Mutant OPAA enzymes with increased catalytic efficiency on organophosphorus compound EA1356
granted -
US 10081658
Truncated HIV envelope proteins (ENV), methods and compositions related thereto
granted -
US 10081669
Therapy for filovirus infection
granted -
US 10064858
Methods and compositions for treating bacterial infections with iron chelators
granted -
US 10040826
Human immunodeficiency virus type 1 (HIV-1) N-terminal deleted GP120 immunogens
granted -
US 9976130
OPAA FL—a mutant enzyme with increased catalytic efficiency on organophosphorus compound GD
granted -
US 9968669
Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome
granted -
US 9919040
Soluble recombinant plasmodium falciparum circumsporozoite protein, use in vaccines, methods of making and uses thereof
granted -
US 9861681
Therapeutic compositions for neutralizing type I interferons, and methods of use
granted -
US 9833437
Small molecule inhibitor of MYD88 for therapeutic treatment against alphavirus and staphylococcal enterotoxin infections and toxin exposure
granted -
US 9683024
Recombinantly expressed plasmodium CelTOS antigen and methods of use thereof
granted -
US 9675572
Intravenous omega-3 fatty acid compositions and method of use
granted -
US 9675684
Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome
granted -
US 9651462
Method and system for sampling and separating submicron-sized particles based on density and/or size to detect the presence of a particular agent
granted